The store will not work correctly when cookies are disabled.
6-chloro-3-[1-(3-chlorophenyl)cyclobutylamino]-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide
ID: ALA383992
PubChem CID: 135467082
Max Phase: Preclinical
Molecular Formula: C15H13Cl2N3O2S2
Molecular Weight: 402.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S1(=O)N=C(NC2(c3cccc(Cl)c3)CCC2)Nc2cc(Cl)sc21
Standard InChI: InChI=1S/C15H13Cl2N3O2S2/c16-10-4-1-3-9(7-10)15(5-2-6-15)19-14-18-11-8-12(17)23-13(11)24(21,22)20-14/h1,3-4,7-8H,2,5-6H2,(H2,18,19,20)
Standard InChI Key: DSCJXNXUTREXCL-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
-0.3041 -0.3485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8442 -0.9677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2251 -1.5077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3150 -0.8886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4486 -1.5767 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.7353 -1.1701 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7353 -0.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4486 0.0747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9471 -1.4226 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.1618 -1.1701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1618 -0.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9479 -0.0876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4286 -0.7581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8672 -2.1618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0373 -2.1618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0185 0.0684 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2543 -0.7602 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.4128 0.0643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1239 -0.3563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8361 0.0559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8390 0.8824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1237 1.2952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4103 0.8848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5471 -0.3558 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 10 1 0
11 12 1 0
12 13 2 0
13 9 1 0
11 8 1 0
5 14 2 0
10 5 1 0
5 15 2 0
5 6 1 0
7 16 1 0
6 7 2 0
13 17 1 0
16 1 1 0
7 8 1 0
1 18 1 0
10 11 2 0
18 19 2 0
4 1 1 0
19 20 1 0
20 21 2 0
1 2 1 0
21 22 1 0
2 3 1 0
22 23 2 0
23 18 1 0
3 4 1 0
20 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 402.33 | Molecular Weight (Monoisotopic): 400.9826 | AlogP: 4.19 | #Rotatable Bonds: 2 |
Polar Surface Area: 70.56 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.97 | CX Basic pKa: 1.23 | CX LogP: 4.28 | CX LogD: 4.28 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.79 | Np Likeness Score: -1.10 |
References
1. Nielsen FE, Ebdrup S, Jensen AF, Ynddal L, Bodvarsdottir TB, Stidsen C, Worsaae A, Boonen HC, Arkhammar PO, Fremming T, Wahl P, Kornø HT, Hansen JB.. (2006) New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells., 49 (14): [PMID:16821773] [10.1021/jm060042j] |